Osteoporosis Clinical Trials in New York

Showing 21-40 of 56 trials

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

NCT00697463

Idiopathic osteoporosis (IOP) is an uncommon disorder in which otherwise healthy young individuals sustain one or more low-trauma fractures. Teriparatide \[PTH(1-34)\], which is FDA approved for treatment of osteoporosis in men and postmenopausal women, works by stimulating bone formation. The investigators hypothesize that teriparatide will significantly increase bone density (BMD) and improve bone structure in premenopausal women with IOP.

MenopauseFractureOsteoporosis

Columbia University22 participantsStarted Aug 2008

Omaha, Nebraska, United States • New York, New York, United States

COMPLETEDPhase 3< 1 mile

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

NCT00925600

This is a phase 3, randomized, double-blind, placebo-controlled study to evaluate new or worsening lens opacifications in men with non-metastatic prostate cancer receiving denosumab for bone loss due to androgen deprivation therapy.

CancerCataractLow Bone Mineral Density+3 more

Amgen769 participantsStarted Nov 2009

Anaheim, California, United States • Laguna Hills, California, United States • Murrieta, California, United States +169 more locations

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Osteoporosis Trials in Other Cities

Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Osteoporosis Prevention After Heart Transplant

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

The Interaction Between Calcium and Vitamin D Intake

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Cyclic Versus Daily Teriparatide on Bone Mass

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

Other Conditions in New York